Electrophysiology Ablation Catheters Market Report 2025

This electrophysiology ablation catheters market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The electrophysiology ablation catheters market size has grown rapidly in recent years. It will grow from $3.49 billion in 2024 to $4.11 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to the rising prevalence of cardiac arrhythmias, increasing geriatric population, growing demand for minimally invasive procedures, improvements in imaging techniques, and expanding healthcare infrastructure.

The electrophysiology ablation catheters market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to the increasing prevalence of cardiac arrhythmias, growing adoption of minimally invasive procedures, rising awareness of early diagnosis, supportive government initiatives, and a surge in geriatric populations with higher cardiac conditions. Major trends in the forecast period include the integration of advanced imaging technologies, advancements in catheter designs and materials, telemedicine applications for remote monitoring and consultations, enhanced integration of wearable technology for continuous cardiac monitoring, and real-time monitoring and data analytics in electrophysiology procedures.

The rising number of patients experiencing heart rhythm problems is anticipated to boost the growth of the electrophysiology ablation catheter market. Individuals with heart rhythm issues, known as arrhythmias, experience irregular heartbeats. This increase in patients is attributed to factors such as aging populations, rising obesity rates, and a greater prevalence of heart conditions. Electrophysiology ablation catheters assist these patients by targeting and eliminating the abnormal heart tissue responsible for irregular heartbeats, helping to restore normal rhythm. For example, according to the Heart Rhythm Society, a US-based non-profit organization, atrial fibrillation (AFib) significantly impacts a global population of approximately 40 million people, with around 6 million affected in the United States. It is projected that by 2030, the number of individuals with AFib in the U.S. will grow to 12.1 million. Consequently, the increasing number of patients with heart rhythm problems is set to drive the expansion of the electrophysiology ablation catheter market.

Major companies in the electrophysiology ablation catheter market are advancing technological innovations, such as multi-channel radiofrequency (RF) generators, to enhance precision, improve treatment outcomes, and effectively address complex arrhythmias. Multi-channel RF generators are devices that produce multiple RF signals simultaneously, allowing for precise targeting and treatment of specific areas in medical or industrial applications. For example, in October 2022, Biosense Webster, a Johnson & Johnson MedTech company based in the US, introduced the HELIOSTAR Balloon Ablation Catheter in Europe. The HELIOSTAR is the first radiofrequency balloon ablation catheter designed for catheter-based cardiac electrophysiological mapping of the atria and cardiac ablation when used with a compatible multi-channel RF generator. It fully integrates with Biosense Webster's CARTO 3 System, a 3D mapping solution. The catheter features a compliant balloon that adapts to various pulmonary vein anatomies, enabling single-shot pulmonary vein isolation (PVI) in approximately 12 seconds.

In January 2024, CardioFocus Inc., a US-based medical device company, acquired the electrophysiology division of Galvanize Therapeutics for an undisclosed amount. This acquisition is intended to boost CardioFocus’s technological capabilities, expand its range of cardiac electrophysiology ablation catheters, and foster innovation in tackling complex cardiac conditions. Galvanize Therapeutics Inc., based in the US, is a biotechnology company specializing in electrophysiology ablation catheters.

Major companies operating in the electrophysiology ablation catheters market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., Stryker Corporation, General Electric Company, Boston Scientific Corporation, Edwards Lifesciences Corporation, Zoll Medical Corporation, Integra LifeSciences Holdings Corporation, Merit Medical Systems Inc., Conmed Corporation, MicroPort Scientific Corporation, AtriCure Inc., AngioDynamics Inc., Esaote S.p.A., Stereotaxis Inc., APN Health LLC, Kardium Inc., Hansen Medical Inc., Acutus Medical Inc., Imricor Medical Systems Inc., Osypka Medical GmbH.

North America was the largest region in the electrophysiology ablation catheters market in 2024. The regions covered in the electrophysiology ablation catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electrophysiology ablation catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Electrophysiology ablation catheters are specialized medical devices used to diagnose and treat abnormal heart rhythms by delivering targeted energy to specific heart areas. They offer advantages such as precise targeting of abnormal heart tissue, effective arrhythmia treatment, shorter recovery periods, and reduced risks associated with the procedure.

The primary types of electrophysiology ablation catheters include lab devices, ablation catheters, and diagnostic catheters. Lab devices encompass tools and equipment necessary for the preparation, testing, and analysis of ablation catheters, which are crucial for ensuring the accuracy and effectiveness of catheter procedures. These devices support functions such as calibration, measurement, and diagnostic testing. Common indications for use are atrial fibrillation (AF), atrioventricular nodal reentrant tachycardia (AVNRT), and Wolff-Parkinson-White (WPW) syndrome. The main end users of these catheters are hospitals and ambulatory surgery centers (ASCs).

The electrophysiology ablation catheters market research report is one of a series of new reports that provides electrophysiology ablation catheters market statistics, including electrophysiology ablation catheters industry global market size, regional shares, competitors with an electrophysiology ablation catheters market share, detailed electrophysiology ablation catheters market segments, market trends and opportunities, and any further data you may need to thrive in the electrophysiology ablation catheters industry. This electrophysiology ablation catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electrophysiology ablation catheter market consists of sales of radiofrequency (RF) ablation EP catheters, cryoablation EP catheters, microwave ablation EP catheters, laser ablation EP catheters, and ultrasound ablation EP catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.